Surgical Salvage of Cancer of the Oropharynx After Chemoradiation

被引:5
作者
Bumpous, Jeffrey M. [1 ]
机构
[1] Univ Louisville, Dept Surg, Div Otolaryngol, James Graham Brown Canc Ctr,Sch Med, Louisville, KY 40292 USA
关键词
Standardize Uptake Value; Locoregional Recurrence; Locoregional Control; Oropharyngeal Cancer; Oropharyngeal Squamous Cell Carcinoma;
D O I
10.1007/s11912-009-0022-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Advanced oropharyngeal squamous cell carcinoma is treated primarily with chemoradiation, with the goal of excellent disease control and preservation of swallowing and articulation functions of the oropharynx. Disease control rates generally are excellent; however, a significant number of patients do not achieve locoregional control of disease. The importance of human papillomavirus expression in predicting successful tumor response, locoregional control, and survival following chemoradiation is increasingly confirmed. Emerging is a clinical profile, viral expression, and genetic expression pattern that can predict success of chemoradiation and indicate which patients are at higher risk for locoregional failure necessitating surgical salvage. Successful surgical salvage depends on restaging at the time of recurrence and the time interval from chemoradiation to recurrence. Although surgical morbidity and mortality remain a challenge in patients undergoing salvage surgery of the oropharynx after radiation failure with or without chemotherapy, they may be mitigated by liberal application of regional and microvascular free flap reconstruction techniques.
引用
收藏
页码:151 / 155
页数:5
相关论文
共 16 条
[1]   Prognostic factors in salvage surgery for recurrent oral and oropharyngeal cancer [J].
Agra, IMG ;
Carvalho, AL ;
Ulbrich, FS ;
de Campos, OD ;
Martins, EP ;
Magrin, J ;
Kowalski, LP .
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2006, 28 (02) :107-113
[2]   Tumor Volume as a Prognostic Factor in Oropharyngeal Squamous Cell Carcinoma Treated With Primary Radiotherapy [J].
Been, Mark J. ;
Watkins, Joanna ;
Manz, Ryan M. ;
Gentry, Lindell R. ;
Leverson, Glen E. ;
Harari, Paul M. ;
Hartig, Gregory K. .
LARYNGOSCOPE, 2008, 118 (08) :1377-1382
[3]  
Chedid Helma Maria, 2008, Braz J Otorhinolaryngol, V74, P532
[4]   Changes in treatment of advanced oropharyngeal cancer, 1985-2001 [J].
Chen, Amy Y. ;
Schrag, Nicole ;
Hao, Yongping ;
Stewart, Andrew ;
Ward, Elizabeth .
LARYNGOSCOPE, 2007, 117 (01) :16-21
[5]   Phase II trial of chemoradiation for organ preservation in resectable stage III or IV squamous cell carcinomas of the larynx or oropharynx: Results of Eastern Cooperative Oncology Group study E2399 [J].
Cmelak, Anthony J. ;
Li, Sigui ;
Goldwasser, Meredith A. ;
Murphy, Barbara ;
Cannon, Michael ;
Pinto, Harlan ;
Rosenthal, David I. ;
Gillison, Maura ;
Forastiere, Arlene A. .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (25) :3971-3977
[6]   Increased viral load correlates with improved survival in HPV-16-associated tonsil carcinoma patients [J].
Cohen, Marc A. ;
Basha, Suzanne R. ;
Reichenbach, Dawn K. ;
Robertson, Erle ;
Sewell, Duane A. .
ACTA OTO-LARYNGOLOGICA, 2008, 128 (05) :583-589
[7]   Prognostic value of FDG-PET in patients with oropharyngeal carcinoma treated with concurrent chemoradiotherapy [J].
Enomoto, Keisuke ;
Inohara, Hidenori ;
Higuchi, Ichiro ;
Hamada, Kenichiro ;
Tomiyama, Yoichiro ;
Kubo, Takeshi ;
Hatazawa, Jun .
MOLECULAR IMAGING AND BIOLOGY, 2008, 10 (04) :224-229
[8]   Predictors of quality of life after treatment for oral cavity and oropharyngeal carcinoma [J].
Gurney, Theresa A. ;
Eisele, David W. ;
Orloff, Lisa A. ;
Wang, Steven J. .
OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2008, 139 (02) :262-267
[9]   Marked differences in survival rate between smokers and nonsmokers with HPV 16-associated tonsillar carcinomas [J].
Hafkamp, Harriet C. ;
Manni, J. J. ;
Haesvoets, A. ;
Voogd, A. C. ;
Schepers, M. ;
Bot, F. J. ;
Hopman, A. H. N. ;
Ramaekers, F. C. S. ;
Speel, Ernst-Jan M. .
INTERNATIONAL JOURNAL OF CANCER, 2008, 122 (12) :2656-2664
[10]   Intensity-modulated chemoradiation for treatment of stage III and IV oropharyngeal carcinoma - The University of California-San Francisco experience [J].
Huang, Kim ;
Xia, Ping ;
Chuang, Cynthia ;
Weinberg, Vivian ;
Glastonbury, Christine M. ;
Eisele, David W. ;
Lee, Nancy Y. ;
Yom, Sue S. ;
Phillips, Theodore L. ;
Quivey, Jeanne M. .
CANCER, 2008, 113 (03) :497-507